Marion Webb
Managing Editor

Marion Webb has been writing about health care issues for nearly two decades as a full-time reporter and freelancer. As the senior business reporter for the San Diego Business Journal, Marion covered new medical innovations at San Diego’s top-ranking research institutions and the medical device and life sciences industry for nearly eight years. She’s also been a regular contributor to the Los Angeles County Medical Association’s Physician Magazine and Physicians News Network focusing on new technologies, practice management, reimbursement and other trendy issues relevant to physician practices and their ability to succeed. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sector, from potentially life-saving devices to help treat patients who otherwise wouldn’t have access to medical care to breakthrough technologies that benefit mankind. Marion earned her BA in communications from UC San Diego and continues to enjoy an active lifestyle in San Diego.
Latest From Marion Webb
MD&M BIOMEDigital 2021: ‘There is No Easy Button On 3D Printing,’ Panelist Says
As medical organizations such as the VHA and Mayo Clinic are positioning themselves to become medical device manufacturers using 3D printing technologies, it opens opportunities and challenges.
Diagnostic Company LumiraDX Goes Public In $5Bn SPAC Merger
LumiraDX secured $400m in new debt financing and will use all proceeds to fund growth.
Invitae Acquires Genosity In $200M Deal, Raises $1.15Bn From Softbank Group
Invitae continues its growth initiative with a $1.15bn investment from Softbank Group and acquisition of Genosity to accelerate oncology testing.
Device Week, 2 April 2021 – Venture Capital Viewpoints, And Exciting Financing Deals For Augmedics And NeuroPace
In this week’s podcast, Medtech Insight managing editor Reed Miller discusses Augmedics’ and NeuroPace’s financing deals, and UK-based reporter Barnaby Pickering offers some insights from Octopus Ventures, a venture capital fund based in London.
CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal
The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.
SeaSpine Holdings Acquires Toronto-Based 7D Surgical For $110M
BTIG analyst expects SeaSpine’s acquisition of 7D Systems will help SeaSpine morph into a procedurally integrated solutions provider.